Pediatrix Medical Group, Inc.

For the period ended Jun 30, 2026. Filed Aug 4, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 4, 2026

MD$31.29-1.7%Stored close · as of Nov 6, 2026

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets as of June 30, 2026 and December 31, 2025 (Unaudited)

Consolidated Balance Sheets

(in thousands, except share data)

	June 30, 2026	December 31, 2025
ASSETS
Current assets:
Cash and cash equivalents	$288,879	$375,241
Short-term investments	115,319	124,482
Accounts receivable, net	227,601	229,665
Prepaid expenses	9,578	12,606
Income taxes receivable	11,404	12,641
Other current assets	7,360	8,879
Total current assets	660,141	763,514
Property and equipment, net	38,704	39,180
Goodwill	1,268,248	1,260,732
Intangible assets, net	14,514	16,862
Operating and finance lease right-of-use assets	35,190	34,330
Deferred income tax assets	56,114	73,922
Other assets	57,431	58,156
Total assets	$2,130,342	$2,246,696
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable and accrued expenses	$301,837	$419,530
Current portion of debt and finance lease liabilities, net	186,183	26,806
Current portion of operating lease liabilities	12,238	11,591
Income taxes payable	1,320	984
Total current liabilities	501,578	458,911
Long-term debt and finance lease liabilities, net	398,060	570,532
Long-term operating lease liabilities	23,475	25,686
Long-term professional liabilities	235,145	238,353
Deferred income tax liabilities	58,709	57,024
Other liabilities	32,398	30,336
Total liabilities	1,249,365	1,380,842
Commitments and contingencies
Shareholders’ equity:
Preferred stock; $.01 par value; 1,000,000 shares authorized; none issued	—	—
Common stock; $.01 par value; 200,000,000 shares authorized; 81,222,774 and 82,976,110 shares issued and outstanding, respectively	812	830
Additional paid-in capital	894,288	947,566
Accumulated other comprehensive (loss) income	(386)	610
Retained deficit	(13,737)	(83,152)
Total shareholders’ equity	880,977	865,854
Total liabilities and shareholders’ equity	$2,130,342	$2,246,696

Consolidated Statements of Income and Comprehensive Income

(in thousands, except per share data)

	Three Months EndedJune 30,		Six Months EndedJune 30,
	2026	2025	2026	2025
Net revenue	$487,783	$468,844	$963,979	$927,203
Operating expenses:
Practice salaries and benefits	336,116	323,502	681,860	660,533
Practice supplies and other operating expenses	19,197	20,614	36,685	39,300
General and administrative expenses	61,291	55,714	121,557	114,318
Depreciation and amortization	5,782	5,313	11,901	10,645
Transformational and restructuring related expenses	8,475	3,834	13,397	10,439
Total operating expenses	430,861	408,977	865,400	835,235
Income from operations	56,922	59,867	98,579	91,968
Investment and other income	4,548	3,727	9,308	8,464
Interest expense	(8,172)	(9,130)	(16,437)	(18,284)
Equity in earnings of unconsolidated affiliate	702	505	1,394	911
Total non-operating expenses	(2,922)	(4,898)	(5,735)	(8,909)
Income before income taxes	54,000	54,969	92,844	83,059
Income tax provision	(14,157)	(15,709)	(23,429)	(23,062)
Net income	$39,843	$39,260	$69,415	$59,997
Other comprehensive income, net of tax
Unrealized holding (loss) gain on investments, net of tax of $145, $140, $297, and $395	(463)	429	(996)	1,208
Total comprehensive income	$39,380	$39,689	$68,419	$61,205
Per common and common equivalent share data:
Net income:
Basic	$0.50	$0.46	$0.87	$0.71
Diluted	$0.49	$0.46	$0.85	$0.70
Weighted average common shares:
Basic	79,440	84,797	79,957	84,653
Diluted	81,412	85,529	82,040	85,517

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.